GlassScriptPhysician profile
Robert S Julian
NPI 1427119791
$11,497.69
in general payments reported to CMS, 2019-2025
25 companies · $498 in 2025
The $498 reported for 2025 was more than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,385 · 2020: $300 · 2021: $1,924 · 2022: $556 · 2023: $973 · 2024: $2,861 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,166 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Travel and Lodging: $473 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,165.70 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Travel and Lodging | $473.16 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $3,573.68 | 2021-2024 | |
| Zimmer Biomet Holdings, INC. | $3,377.85 | 2019-2020 | |
| Inspire Medical Systems, INC. | $990.21 | 2019-2025 | Inspire |
| Depuy Synthes Sales INC. | $758.79 | 2020-2025 | Trumatch, Matrixmidface, Ascent |
| Kls-Martin L.P. | $718.75 | 2019-2025 | |
| Axogen | $452.37 | 2019-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Stryker Corporation | $226.68 | 2020-2024 | Na, Medpor Titan |
| Astellas Pharma US INC | $224.98 | 2019-2023 | |
| Livanova USA, INC. | $207.47 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Janssen Biotech, INC. | $176.81 | 2019-2023 | Erleada |
| Antares Pharma, INC. | $173.26 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $106.63 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $93.28 | 2020-2024 | |
| Immunitybio, INC. | $76.55 | 2024-2025 | |
| Smith+Nephew, INC. | $46.49 | 2023-2024 | Stravix Pl, Renasys Go V2 Home, Pico |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $40.18 | 2020 | |
| Myriad Genetic Laboratories, INC. | $35.17 | 2022 | |
| Implant Direct Sybron International LLC | $34.83 | 2019 | |
| Nobel Biocare USA | $34.83 | 2023 | Nobelactive |
| Blue Earth Diagnostics | $28.35 | 2025 | Posluma |
| Sumitomo Pharma America, INC. | $26.00 | 2023 | Orgovyx |
| Medtronic USA, INC. | $23.94 | 2019 | |
| Sun Pharmaceutical Industries INC. | $23.94 | 2024 | |
| Geistlich Pharma, North America, INC. | $23.66 | 2023 | Bio-Gide |
| Accord Healthcare, INC. | $22.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Julian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.